1 false false false false false false false false false false true false false false false true true No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 12114139 2023-08-01 2024-07-31 12114139 2024-07-31 12114139 2023-07-31 12114139 2022-08-01 2023-07-31 12114139 2023-07-31 12114139 2022-07-31 12114139 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 12114139 bus:Director1 2023-08-01 2024-07-31 12114139 core:WithinOneYear 2024-07-31 12114139 core:WithinOneYear 2023-07-31 12114139 core:ShareCapital 2024-07-31 12114139 core:ShareCapital 2023-07-31 12114139 core:RetainedEarningsAccumulatedLosses 2024-07-31 12114139 core:RetainedEarningsAccumulatedLosses 2023-07-31 12114139 bus:Director1 2023-07-31 12114139 bus:Director1 2022-07-31 12114139 bus:SmallEntities 2023-08-01 2024-07-31 12114139 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 12114139 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 12114139 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 12114139 bus:FullAccounts 2023-08-01 2024-07-31
COMPANY REGISTRATION NUMBER: 12114139
Aqueduct Healthcare Limited
Filleted Unaudited Financial Statements
31 July 2024
Aqueduct Healthcare Limited
Financial Statements
Year Ended 31st July 2024
Contents
Page
Chartered Certified Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements
1
Statement of Financial Position
2
Notes to the Financial Statements
3
Aqueduct Healthcare Limited
Chartered Certified Accountants Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Aqueduct Healthcare Limited
Year Ended 31st July 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Aqueduct Healthcare Limited for the year ended 31st July 2024, which comprise the statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. This report is made solely to the director of Aqueduct Healthcare Limited in accordance with the terms of our engagement letter dated 20th July 2019. Our work has been undertaken solely to prepare for your approval the financial statements of Aqueduct Healthcare Limited and state those matters that we have agreed to state to you in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Aqueduct Healthcare Limited and its director for our work or for this report.
It is your duty to ensure that Aqueduct Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Aqueduct Healthcare Limited. You consider that Aqueduct Healthcare Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of Aqueduct Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
MJ GREEN ACCOUNTANCY SERVICES LTD Chartered Certified Accountants
Unit 10 Silver End Business Park Brettell Lane Brierley Hill West Midlands DY5 3LG
17 April 2025
Aqueduct Healthcare Limited
Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
Current Assets
Cash at bank and in hand
34,089
34,089
Creditors: amounts falling due within one year
5
6,965
8,965
--------
--------
Net Current Assets
27,124
25,124
--------
--------
Total Assets Less Current Liabilities
27,124
25,124
--------
--------
Net Assets
27,124
25,124
--------
--------
Capital and Reserves
Called up share capital
100
100
Profit and loss account
27,024
25,024
--------
--------
Shareholders Funds
27,124
25,124
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31st July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 17 April 2025 , and are signed on behalf of the board by:
K Zenonos
Director
Company registration number: 12114139
Aqueduct Healthcare Limited
Notes to the Financial Statements
Year Ended 31st July 2024
1. General Information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 10 Silver End Business Park, Brettell Lane, Brierley Hill, West Midlands, DY5 3LG.
2. Statement of Compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting Policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
4. Employee Numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
5. Creditors: amounts falling due within one year
2024
2023
£
£
Corporation tax
6,105
6,105
Other creditors
860
2,860
-------
-------
6,965
8,965
-------
-------
6. Director's Advances, Credits and Guarantees
During the year the director entered into the following advances and credits with the company:
Balance brought forward and outstanding
2024
2023
£
£
K Zenonos
( 860)
( 860)
----
----
The credits to the director were made on an interest free basis and are repayable on demand.